Amy J Wagers

USPTO Granted Patents = 17 (Patent Applications = 20)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 42(Granted Patents)

Location History:

Brookline, MA (US) (2012)
Cambridge, MA (US) (2016 - 2024)

Company Filing History:

The Brigham and Women's Hospital, Inc.

patents

3 out of 1,036

Children's Medical Center Corporation

patents

4. 2 out of 72

Joslin Diabetes Center, Inc.

patents

5. 1 out of 2,893

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 2012-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12415001 - RNA-guided systems for in vivo gene editing (2025-09-16),

2. 12097174 - Methods and agents that enhance myogenic progenitor cell engraftment (2024-09-24),

3. 11963964 - Small molecules for mouse satellite cell proliferation (2024-04-23),

4. 11725033 - GDF11 variants and uses thereof (2023-08-15),

5. 11666665 - RNA-guided systems for in vivo gene editing (2023-06-06),

6. 11612639 - Methods and compositions for rejuvenating skeletal muscle stem cells (2023-03-28),

7. 11534418 - Methods and agents that enhance myogenic progenitor cell engraftment (2022-12-27),

8. 11426400 - Methods of increasing satellite cell proliferation with vorinostat or bosutinib (2022-08-30),

9. 11026952 - Small molecules for mouse satellite cell proliferation (2021-06-08),

10. 10660902 - Method of increasing satellite cell proliferation with an HDAC inhibitor (2020-05-26),

11. 10092627 - Methods and compositions for rejuvenating skeletal muscle stem cells (2018-10-09),

12. 9951340 - Compositions and methods for bacterial delivery of polypeptides (2018-04-24),

13. 9782417 - Methods of increasing satellite cell proliferation with kinase inhibitors (2017-10-10),

14. 9771560 - High-throughput image-based chemical screening in zebrafish blastomere cell culture (2017-09-26),

15. 9434779 - Growth differentiation factor 11 (GDF-11) for treatment of diastolic heart failure (2016-09-06),

Title: The Innovative Journey of Amy J Wagers

Introduction: Amy J Wagers is a pioneering inventor based in Cambridge, MA, known for her groundbreaking contributions to the field of biotechnology and regenerative medicine.

Latest Patents: Amy J Wagers holds several patents related to stem cell research, tissue regeneration, and aging interventions, showcasing her commitment to advancing healthcare through innovative technologies.

Career Highlights: With a distinguished career in academia and industry, Amy J Wagers has held key research positions at leading institutions, where she has led cutting-edge projects focused on harnessing the potential of stem cells for therapeutic applications.

Collaborations: Throughout her career, Amy J Wagers has collaborated with top scientists, medical professionals, and biotech companies to translate her research findings into tangible solutions that have the potential to revolutionize the healthcare landscape.

Conclusion: Amy J Wagers' relentless pursuit of scientific excellence and her passion for pushing the boundaries of innovation continue to inspire the next generation of inventors and researchers in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.